rVSVΔG-MARV-GP vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rVSVΔG-MARV-GP vaccine, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health [Phase 1]